Coffee and sleep: Benefits and risks
Progress in Brain Research · 2024 · 81-114
DOI: 10.1016/bs.pbr.2024.06.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Progress in Brain Research, 2024. Verfasst von Yavar Bagheri Davisaraei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran; Department of Physiology, School of Medicine, Semnan University o…. Hauptthemen laut MEDLINE: Coffee, Caffeine, Sleep. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran; Department of Physiology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
- College of International Education, Dalian Medical University, Dalian, China.
- Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
- Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran; Department of Physiology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. Electronic address: rashidy-pour@sem…
Zitieren
APA
Bagheri Davisaraei, Y., Nateghi, S., Rashidipour, H., Raise-Abdullahi, P., & Rashidy-Pour, A. (2024). Coffee and sleep: Benefits and risks. Progress in Brain Research, 81-114. https://doi.org/10.1016/bs.pbr.2024.06.014
Vancouver
Bagheri Davisaraei Y, Nateghi S, Rashidipour H, Raise-Abdullahi P, Rashidy-Pour A. Coffee and sleep: Benefits and risks. Progress in Brain Research. 2024:81-114. doi:10.1016/bs.pbr.2024.06.014
BibTeX
@article{BagheriDavisaraei2024,
author = {Bagheri Davisaraei, Yavar and Nateghi, Sepide and Rashidipour, Hamed and Raise-Abdullahi, Payman and Rashidy-Pour, Ali},
title = {Coffee and sleep: Benefits and risks},
journal = {Progress in Brain Research},
year = {2024},
pages = {81--114},
doi = {10.1016/bs.pbr.2024.06.014}
}
EUVIMED